Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GenetiRate was a Tucson, Arizona-based aquaculture biotechnology company founded in 2018 around a University of Arizona-originated assay and sorting technology. The company developed a proprietary metabolic rate-based diagnostic and sorting platform for aquatic animals, eggs, embryos, hatchlings, and tissues to identify individuals with superior growth potential and feed efficiency. Its products and services were aimed at improving sustainability and production efficiency in aquaculture rather than human therapeutics. GenetiRate was acquired by IMV Technologies in February 2021, and its technology became part of IMV's aquaculture biotechnology offering.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GenetiRate.